These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8959289)
1. Phencyclidine alters regional concentrations of neuropeptide Y and peptide YY in rat brain. Sakai K; Maeda K; Okuyama S; Tanaka C Biol Psychiatry; 1996 Dec; 40(12):1246-54. PubMed ID: 8959289 [TBL] [Abstract][Full Text] [Related]
2. Differential regulation of neuropeptide Y systems in limbic structures of the rat. Midgley LP; Bush LG; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1993 Nov; 267(2):707-13. PubMed ID: 8246145 [TBL] [Abstract][Full Text] [Related]
3. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Midgley LP; Bush LG; Gibb JW; Hanson GR Brain Res; 1992 Oct; 593(1):89-96. PubMed ID: 1360868 [TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments. Thompson LT; Disterhoft JF J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Nicholson KL; Jones HE; Balster RL Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937 [TBL] [Abstract][Full Text] [Related]
6. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D; Zhang J; Engel JA; Svensson L Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002 [TBL] [Abstract][Full Text] [Related]
7. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM; Steele TD; Sharpe LG J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [TBL] [Abstract][Full Text] [Related]
8. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710 [TBL] [Abstract][Full Text] [Related]
9. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells. Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729 [TBL] [Abstract][Full Text] [Related]
10. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. Westwood SC; Hanson GR J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. Umino A; Takahashi K; Nishikawa T Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556 [TBL] [Abstract][Full Text] [Related]
12. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. Arvanov VL; Wang RY J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680 [TBL] [Abstract][Full Text] [Related]
13. Effects of single and repeated phencyclidine administration on [3H]flunitrazepam binding in rat brain. Abe S; Suzuki T; Endo K; Hori T; Arai H Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):133-40. PubMed ID: 15610955 [TBL] [Abstract][Full Text] [Related]
14. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia. Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263 [TBL] [Abstract][Full Text] [Related]
15. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs. Gruber SH; Nomikos GG; Mathé AA Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702 [TBL] [Abstract][Full Text] [Related]
16. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons. Wang C; Anastasio N; Popov V; Leday A; Johnson KM Neuroscience; 2004; 125(2):473-83. PubMed ID: 15062989 [TBL] [Abstract][Full Text] [Related]
17. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo. Malmström RE; Lundberg JN; Weitzberg E Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028 [TBL] [Abstract][Full Text] [Related]
18. Effect of haloperidol treatment on immunoreactive neuropeptide Y secretion into lateral cerebral ventricle of rats. Obuchowicz E; Stachura Z Pol J Pharmacol; 2000; 52(3):223-7. PubMed ID: 11055580 [TBL] [Abstract][Full Text] [Related]
19. Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Gao XM; Hashimoto T; Tamminga CA Synapse; 1998 May; 29(1):14-28. PubMed ID: 9552172 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Hanania T; Hillman GR; Johnson KM Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]